Threat of drug resistant Staphylococcus aureus to health in Nepal

BMC Infectious Diseases

Volumn 14, Issue 1, 2014, Pages

  Ansari, Shamshul ^a   Nepal, Hari P ^a   Gautam, Rajendra ^a   Rayamajhi, Nabin ^a   Shrestha, Sony ^a   Upadhyay, Goma ^a   Acharya, Anju ^a   Chapagain, Moti L ^a  

^a CHITWAN MEDICAL COLLEGE   (Nepal)

Author keywords

Inducible clindamycin resistance; MRSA; Nepal; Staphylococcus aureus

Indexed keywords

CEFOXITIN; CLINDAMYCIN; METICILLIN; OXACILLIN; TEICOPLANIN; VANCOMYCIN;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM CULTURE; BACTERIUM ISOLATE; BLOOD; CHILD; FEMALE; HUMAN; HUMAN CELL; INFANT; MAJOR CLINICAL STUDY; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NEPAL; NONHUMAN; PUS; SPUTUM; STAPHYLOCOCCUS AUREUS; URINE; VERY ELDERLY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; MALE; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; NEPAL; RETROSPECTIVE STUDIES; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; YOUNG ADULT;

EID: 84899094452     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-14-157     Document Type: Article

References (37)

1. Foster TJ. The Staphylococcus aureus " superbug" J Clin Invest 2004, 114:1693-1696. 10.1172/JCI200423825, 535074, 15599392.
2. Lowy FD. Staphylococcus aureus infection. N England J Med 1998, 339:520-532.
3. Boyce JM. Epidemiology and prevention of nosocomial infections. The staphylococci in human disease 1997, 309-329. New York: Churchill Livingstone, Crossley KB, Archer GL.
4. Shopsin B, Kreiswirth BN. Molecular epidemiology of methicillin-resistant Staphylococcus aureus. Emerg Infect Dis 2001, 7:323-326. 10.3201/eid0702.010236, 2631714, 11294733.
5. Cosgrove SE, Sakoulas G, Perencevich EN, Schwaber MJ, Karchmer AW, Carmeli Y. Comparison of mortality associated with methicillin resistant and methicillin sensitive Staphylococcus aureus bacteriemia: a meta analysis. Clin Infect Dis 2003, 36:53-59. 10.1086/345476, 12491202.
6. Engemann JJ, Carmeli Y, Cosgrove SE, Fowler VG, Bronstein MZ, Trivette SL, Briggs JP, Sexton DJ, Kaye KS. Adverse clinical and economic outcomes attributable to methicillin resistance among patients with Staphylococcus aureus surgical site infection. Clin Infect Dis 2003, 36:592-598. 10.1086/367653, 12594640.
7. Livermore DM. Introduction: the challenge of multiresistance. Int J Antimicrob 2007, 29:51-57.
8. Park DW, Kim MJ, Yang JA, Jeong HW, Sohn JW, Chun BC. Risk factors for isolation of low-level mupirocin-resistant versus susceptible methicillin-resistant Staphylococcus aureus from patients in intensive care units. J Infect 2007, 54:337-342. 10.1016/j.jinf.2006.06.008, 16860870.
9. Manzur A, Vidal M, Pujol M, Cisnal M, Hornero A, Masuet C, Peña C, Gudiol F, Aziza J. Predictive factors of methicillin resistance among patients with Staphylococcus aureus bloodstream infections at hospital admission. J Hosp Infect 2007, 66:135-141. 10.1016/j.jhin.2007.03.015, 17513007.
10. Steinberg JP, Clark CC, Hackman BO. Nosocomial and community acquired Staphylococcus aureus bacteremias from 1980 to 1993: impact of intravascular devices and methicillin resistance. Clin Infect Dis 1996, 23:255-259. 10.1093/clinids/23.2.255, 8842259.
11. Emori TG, Gaynes RP. An overview of nosocomial infections, including the role of the microbiology laboratory. Clin Microbiol Rev 1993, 6:428-442. 358296, 8269394.
12. Deresinski S. Methicillin-resistant Staphylococcus aureus: an evolutionary, epidemiologic, and therapeutic odyssey. Clin Infect Dis 2005, 40:562-573. 10.1086/427701, 15712079.
13. Fluit AC, Wielders CL, Verhoef J, Schmitz FJ. Epidemiology and susceptibility of 3,051 Staphylococcus aureus isolates from 25 university hospitals participating in the European SENTRY study. J Clin Microbiol 2001, 39:3727-3732. 10.1128/JCM.39.10.3727-3732.2001, 88419, 11574603.
14. Herold BC, Immergluck LC, Maranan MC, Lauderdale DS, Gaskin RE, Boyle-Vavra S, Leitch CD, Daum RS. Community acquired methicillin-resistant Staphylococcus aureus in children with no identified predisposing risk. J American Med Assoc 1998, 279:593-598.
15. Salmenlinna S, Lyytikainen O, Vuopio-Varkila J. Community acquired methicillin-resistant Staphylococcus aureus, Finland. Emerging Infect Dis 2002, 8:602-607. 10.3201/eid0806.010313, 2738488, 12023917.
16. Mandell G, Douglas J, Bennett R. Principles and practice of infectious disease 1995, Edinburgh, United Kingdome: Churchill Livingstone Ltd., 4.
17. National Committee for Clinical Laboratory Standards (NCCLS) Performance standards for antimicrobial susceptibility testing 2000, Wayne PA, USA: NCCLS, 7, Vol. 20, National Committee for Clinical Laboratory Standards (NCCLS).
18. HD I. Clinical microbiology procedures handbook 2004, ASM press: Washington DC, 2.
19. Clinical and Laboratory Standard Institute (CLSI) Performance standards for antimicrobial susceptibility testing 2006, Wayne, PA: USA:CLSI: M100-S16, Clinical and Laboratory Standard Institute (CLSI).
20. Clinical and Laboratory Standards Institute (CLSI) Performance standards for antimicrobial susceptibility testing, 17th informational supplement 2007, Wayne, PA: USA:CLSI: M100-S17, Clinical and Laboratory Standards Institute (CLSI).
21. Smolinski MS, Hamburg MA, Lederberg J. Microbial threats to health: emergence, detection and response 2003, Washington: Institute of Medicine, 32.
22. Waldvogel FA. Staphylococcus aureus (including staphylococcal toxic shock). Mandell, Douglas and Bennett's principles and practice of infectious diseases 2000, Philadelphia, PA: CV, A Harcourt Health Sciences Co, Mandell GL, Bennett JE, Dolin R, 5.
23. Tiwari HK, Das AK, Sapkota D, Sivarajan K, Pahwa VK. Methicillin resistant Staphylococcus aureus: prevalence and antibiogram in a tertiary care hospital in western Nepal. J Infect Dev Ctries 2009, 3(9):681-684.
24. Shakya B, Shrestha S, Mitra T. Nasal carriage rate of methicillin resistant Staphylococcus aureus among at national medical college teaching hospital, Birgunj, Nepal. Nepal Med Coll J 2010, 12(1):26-29.
25. Mishra SK, Rijal BP, Pokhrel BM. Emerging threat of multidrug resistant bugs-Acinetobacter calcoaceticus baumannii complex and methicillin resistant Staphylococcus aureus. BMC Research Notes 2013, 6:98-103. 10.1186/1756-0500-6-98, 3605284, 23497675.
26. Sanjana RK, Shah R, Chaudhary N, Singh YI. Prevalence and antimicrobial susceptibility pattern of methicillin-resistant Staphylococcus aureus (MRSA) in CMS-teaching hospital: a preliminary report. Journal of College of Medical Sciences-Nepal 2010, 6(1):1-6.
27. Baral R, Khanal B, Acharya A. Antimicrobial susceptibility patterns of clinical isolates of Staphylococcus aureus in Eastern Nepal. Health Renaissance 2011, 9(2):78-82.
28. Shrestha B, Pokhrel BM, Mohapatra TM. Antibiotic susceptibility pattern of nosocomial isolates of Staphylococcus aureus in a tertiary care hospital, Nepal. J Nepal Med Assoc 2009, 48(175):234-238.
29. Kumari N, Mohapatra TM, Singh YI. Prevalence of methicillin-resistant Staphylococcus aureus (MRSA) in a tertiary-care hospital in Eastern Nepal. J Nepal Med Assoc 2008, 47(170):53-56.
30. Sader HS, Gales AC, Jones RN. Antimicrobial activity of linezolid against gram-positive cocci isolated in Brazil. Braz J Infect Dis 2001, 5:171-176. 10.1590/S1413-86702001000400002, 11712961.
31. Cormican MG, Jones RN. Emerging resistance to antimicrobial agents in gram-positive bacteria. Drugs 1996, 51:6-12. 10.2165/00003495-199600511-00004, 8724811.
32. Shittu AO, Lin J. Antimicrobial susceptibility patterns and characterization of clinical isolates of Staphylococcus aureus in Kwazulu-Natal province, South Africa. BMC Infect Dis 2006, 6:125-137. 10.1186/1471-2334-6-125, 1564024, 16875502.
33. Centers for Disease Control and Prevention Staphylococcus aureus resistance to vancomycin in the United States of America. MMWR 2002, 51:565-567. Centers for Disease Control and Prevention.
34. Classen M, Nouwe J, Fang N, Ott A, Verbrugh H, Hofman A, Vanbelkum A, Uitterlinder A. Staphylococcus aureus nasal carriage is not associated with known polymorphism in the vitamin D receptor gene. FEMS Immunol Med Microbiol 2005, 43:173-176. 10.1016/j.femsim.2004.08.002, 15681147.
35. Lim HS, Lee H, Roh KH, Yum JH, Yong D, Lee K, Chong Y. Prevalence of inducible clindamycin resistance in Staphylococcal isolates at a Korean tertiary care hospital. Yonsei Med J 2006, 47:480-484. 10.3349/ymj.2006.47.4.480, 2687727, 16941736.
36. Rai CKS. Antibiotic susceptibility patters of Staphylococcus aures. J Nepal MedicalAssociation 2001, 40:138.
37. Subedi S, Brahmadarhan KN. Antimicrobial susceptibility pattern of clinical isolates of Staphylococcus aureus in Nepal. Clinical microbiology infect 2005, 11(3):253-237.